Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹19Cr
Rev Gr TTM
Revenue Growth TTM
57.83%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

YCCL
VS
| Quarter | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | 212.8 | 28.0 | -21.7 | 48.7 | 67.7 |
| 11 | 25 | 35 | 32 | 27 | 48 | 48 |
Operating Profit Operating ProfitCr |
| 6.4 | -1.1 | 7.9 | -1.2 | 8.8 | -2.8 | 3.5 |
Other Income Other IncomeCr | 3 | 2 | 1 | 0 | 1 | 2 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | 1 | 4 | -1 | 3 | 0 | 1 |
| 1 | 0 | 1 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | | 4.8 | -312.2 | -33.3 | 83.4 | -45.7 |
| 22.4 | 3.0 | 7.5 | -5.0 | 6.4 | -0.6 | 2.1 |
| 0.0 | 0.0 | 1.8 | -1.1 | 1.1 | -0.2 | 0.5 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 88.3 | 10.5 | 26.0 |
| 36 | 67 | 75 | 96 |
Operating Profit Operating ProfitCr |
| 1.3 | 3.8 | 1.6 | 0.4 |
Other Income Other IncomeCr | 4 | 1 | 3 | 2 |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 |
| 4 | 2 | 2 | 1 |
| 1 | 1 | 1 | 0 |
|
| | -63.6 | 29.9 | -53.1 |
| 9.3 | 1.8 | 2.1 | 0.8 |
| 2.4 | 0.7 | 0.8 | 0.3 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 14 | 19 | 19 |
| 7 | 20 | 21 |
Current Liabilities Current LiabilitiesCr | 6 | 15 | 18 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 0 | 0 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 20 | 51 | 56 |
Non Current Assets Non Current AssetsCr | 7 | 4 | 3 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | -16 | -2 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 18 | 1 |
|
Free Cash Flow Free Cash FlowCr | 0 | -16 | -3 |
| -7.8 | -1,300.3 | -151.0 |
CFO To EBITDA CFO To EBITDA% | -54.6 | -622.4 | -194.0 |
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 50 | 25 |
Price To Earnings Price To Earnings | 0.0 | 39.7 | 15.3 |
Price To Sales Price To Sales | 0.0 | 0.7 | 0.3 |
Price To Book Price To Book | 0.0 | 1.3 | 0.6 |
| 6.9 | 21.8 | 27.5 |
Profitability Ratios Profitability Ratios |
| 3.4 | 6.2 | 3.8 |
| 1.3 | 3.8 | 1.6 |
| 9.3 | 1.8 | 2.1 |
| 19.1 | 6.6 | 7.1 |
| 16.5 | 3.2 | 4.0 |
| 12.4 | 2.3 | 2.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Yasons Chemex Care Limited is a Gujarat-based manufacturer and trader specializing in a diversified portfolio of **dyestuffs, chemical intermediates, and Fast-Moving Consumer Goods (FMCG)**. As a subsidiary of **Yash Chemex Limited**, the company operates a vertically integrated model designed to capture value across the chemical supply chain while expanding into high-margin consumer personal care segments.
---
### Integrated Manufacturing & Strategic Infrastructure
The company’s operations are strategically concentrated in Gujarat’s premier chemical industrial zones, providing a competitive advantage through shared infrastructure and regulatory ease.
| Facility | Location | Strategic Advantage |
| :--- | :--- | :--- |
| **Unit-1** | Changodar, Sanand, Ahmedabad | Located in Shreeji Krupa Industrial Estate; focused on FMCG and specialty lines. |
| **Unit-2** | Vatva, Ahmedabad | Situated in GIDC Phase-2; provides direct access to the **Common Effluent Treatment Plant (CETP)** for efficient waste management. |
**Operational Synergy:** Proximity to other chemical manufacturers in Gujarat facilitates **knowledge sharing, collaborative R&D, and optimized transportation** of raw materials. The company prioritizes **sustainability** through advanced waste management initiatives and environmentally friendly manufacturing techniques.
---
### Diversified Product Ecosystem
Yasons operates under a single reportable business segment but maintains three distinct product verticals:
#### 1. Chemicals & Dyestuffs
* **Core Portfolio:** High-quality **dyestuffs, pigment pastes, and chemical intermediates**.
* **Market Dominance:** The **Textiles segment** is the primary revenue driver, commanding a **65.6% market share** as of 2024.
* **Growth Catalyst:** The **Printing Ink** industry is projected as the fastest-growing segment through **2033**, driven by the superior color density of dye-based inks over pigments.
#### 2. FMCG & Personal Care
* **Product Range:** Includes **Hair Re-Growth Oil, perfumes, deodorants, hand-made soaps, hand sanitizers, and skincare essentials**.
* **Bespoke Manufacturing:** The company has expanded into **customized product manufacturing**, tailoring chemical and FMCG solutions to specific institutional client requirements.
#### 3. Trading Operations
* **Scope:** Distribution and trading of **all kinds of chemicals**, leveraging the parent company’s network to provide a comprehensive sourcing solution for clients.
---
### Capital Structure & IPO Fund Utilization
The company successfully transitioned to the public markets via an **Initial Public Offer (IPO)** on the **NSE EMERGE** platform on **August 3, 2023**.
* **Total Funds Raised:** **INR 20.57 Crore** (at **INR 40** per share).
* **Capital Expansion:** Post-IPO, paid-up equity share capital increased from **Rs. 14.16 crore** to **Rs. 19.30 crore**.
* **Utilization Status:** As of May 2025, issue-related expenses of **Rs. 339.37 lakhs** have been fully utilized. Remaining proceeds are earmarked for scaling manufacturing capacity and strengthening the business footprint.
* **Reinvestment Strategy:** Management maintained a **zero dividend payout** for FY 2023-24, transferring **100% of Net Profit (INR 1.24 crore)** to reserves to fund future development.
---
### Financial Performance & Subsidiary Growth
Yasons has demonstrated resilience despite global geopolitical volatility and inflationary pressures.
**Standalone Financial Summary:**
| Metric (Rs. in Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :---: | :---: | :---: |
| **Revenue from Operations** | **45.84** | **47.67** | **36.77** |
| **EBITDA** | **2.17** | **4.67** | - |
| **Profit After Tax (PAT)** | **1.61** | **1.24** | **3.43** |
**Subsidiary Performance (Rishit Polysurf LLP):**
The company holds a **99% stake** in Rishit Polysurf LLP. This subsidiary is a significant growth engine:
* **FY25 H1 Performance:** Reported assets of **₹18.56 crore** and a net profit of **₹29.63 lakhs**.
* **Consolidated Impact:** In FY24, consolidated revenue reached **Rs. 69.24 crore**, an **88.30% year-on-year increase**, largely driven by the integration of this subsidiary.
---
### Risk Management & Mitigation Framework
The company employs a structured **Risk Management Policy** overseen by the Board and Audit Committee to navigate market uncertainties.
#### Financial & Market Risks
* **Price Volatility:** Exposure to **Active Pharmaceutical Ingredients (APIs)** and raw material price cycles. The company currently does **not use derivative contracts** for hedging.
* **Liquidity & Debt:** Risk is rated **very low**. The company relies on **operating cash flows and equity**. Non-current borrowings were reduced from **Rs. 77.37 lakh** (FY23) to **Rs. 42.08 lakh** (FY24). There are **no short-term bank loans** outstanding.
* **Credit Risk:** Managed via a simplified **Expected Credit Loss (ECL) model**; the company has a negligible history of bad debts.
#### Employee Benefit Obligations (Gratuity)
The company manages long-term liabilities with a weighted average duration of **9.32 years**. Key risks include:
* **Actuarial Risk:** Potential for salary growth to exceed assumptions.
* **Market Risk:** Sensitivity to the **discount rate** (lower rates increase the Defined Benefit Obligation).
* **Legislative Risk:** Potential changes to the **Payment of Gratuity Act**.
---
### Governance & Compliance Outlook
While the company maintains a **statutory compliance management system** audited by external chartered accountants, it has identified areas for administrative improvement:
* **Compliance Gaps:** In FY 2023-24, the company noted a temporary absence of an **Internal Auditor** and delays in filing certain statutory forms (e-Form MGT 14).
* **Transparency:** Management is addressing a noted gap in **Information Technology** updates regarding the corporate website to improve investor communication.
* **CSR Status:** Currently exempt from CSR Committee requirements under **Section 135(1)** of the Companies Act.
### Strategic Roadmap
Yasons Chemex Care is positioned to capitalize on the fact that the **Indian chemical industry** currently contributes only **3% to global production**, suggesting a significant runway for domestic players. The strategy focuses on **multi-site manufacturing prowess**, **bespoke chemical solutions**, and the transition toward **eco-friendly specialty chemicals** to capture higher market share in both domestic and emerging international markets.